Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers have developed a new approach to generate T-cells faster, using polarized Th17 cells that can effectively eradicate tumors in just four days. This breakthrough has immediate clinical implications, offering a potentially long-lived and effective therapy for patients with advanced solid tumors.
Researchers have developed a new treatment that induces an integrated immune response in tumors of patients with pancreatic and colorectal cancers, which are resistant to immunotherapy. The treatment, plerixafor, works by interrupting an immunosuppressive pathway, allowing critical immune cells to infiltrate the tumors.
A national multi-institutional study found that cancer patients and their medical teams benefited from sharing symptoms in real time using web- or telephone-based reporting systems. The system improved patient satisfaction, quality of life, physical function, reduced emergency room visits, and lengthened survival.
A new Northwestern Medicine study found that patients treated by highly skilled surgeons have better long-term survival after surgery for colon cancer. The study showed a 70% lower risk of dying over five years compared to patients with less skilled surgeons.
A study by Massachusetts General Hospital found that patients with significant decision conflict prior to cancer surgery are less active after surgery. The researchers used a smartphone app and sensor data to measure physical activity levels at 30, 60, and 90 days after surgery.
Researchers at VCUarts and Massey Cancer Center developed a digital life review therapy, 'VoicingHan,' which improved symptoms and spiritual well-being in patients. The project was recognized for its innovative approach to palliative care.
A survey of 1038 healthcare professionals reveals that 69% believe patients' access to standard care treatment has been compromised during the pandemic. The study also found that 42% felt at risk of poor wellbeing and 34% showed signs of burnout, but most staff reported being able to work well despite challenges.
Researchers used AI to analyze MRI brain scans of patients with glioblastoma, identifying a significant predictor of overall and progression-free survival: the amount of muscle in the temporalis muscle. Patients with higher muscle mass had improved survival rates, highlighting a potential tool for personalized treatment planning.
A new study examined recent data on African American patients with early-stage non-small cell lung cancer and found that while Black patients are now more likely to receive effective treatments, disparities persist. The use of surgery remained a significant disparity across racial groups, despite increasing utilization over time.
A recent study published in JAMA Surgery found that low muscle mass and quality are linked to greater post-operative complications, hospitalization, and mortality in patients with colon cancer following colon resection surgery. The researchers followed 1,630 patients and used preoperative CT scans to analyze body composition.
A study published in Communications Biology found that inflammation from high IL-6 levels leads to psoriasis-like dermatitis. Researchers propose targeting IL-6 as a potential approach to preventing the condition.
A new study creates a detailed portrait of the immune response in pancreatic cancer, highlighting individual differences and pointing to the need for tailored treatments. The research identifies a potential biomarker, TIGIT, that may be targeted by future therapies.
A study by American College of Surgeons found that watch-and-wait strategy is an option for select patients with stages I to III rectal cancer. The approach, which skips operation, shows similar results in terms of local regrowth and disease-specific survival rates compared to surgical treatment.
A phase II trial shows similar safety and efficacy with single- and multiple-fraction treatment for patients with limited oligometastases. The study found comparable survival rates, local control rates, and disease-free survival rates between the two treatment groups.
Scientists identified an antibody that blocks a signaling molecule in vascular system, causing tumor lymph vessels to die and preventing metastasis. This approach may lead to new ways to block the spread of tumor cells.
A study analyzing US cancer data reveals patients from rural regions and lower-income households often have advanced liver cancer at diagnosis and face higher mortality rates. This highlights the need for targeted quality improvement interventions to address healthcare disparities affecting these populations.
A new 'next generation' BRAF inhibitor, PLX8394, has shown promising results in an early patient trial for treating various types of cancer. The treatment, taken with cobicistat, resulted in a partial response in 22% of patients, including those with glioma and bowel cancer.
A Winship Cancer Institute study shows that advanced molecular imaging with fluciclovine improves disease-free survival rates for patients with recurring prostate cancer after prostatectomy. The trial found a 12% better cancer control rate at three years, persisting at four years.
A new study found that a faecal immunochemical test (FIT) is almost 100% accurate at ruling out bowel cancer in patients with suspicious symptoms. FIT has been shown to be as sensitive as colonoscopy, the current gold standard for detection of colorectal cancer.
A UCSF-CHOP study found that patients under 25 with pediatric cancer were more likely to remain on private insurance for longer durations compared to their older peers. Brief disruptions in insurance have been associated with harmful health consequences, highlighting the importance of the ACA's dependent coverage provision.
A new staging system called STAR-CAP has been developed to predict outcomes and inform treatment decisions for men with non-metastatic prostate cancer. The system, which uses patient, tumor, and outcome data from nearly 20,000 patients, has been validated and shows strong prognostic power.
Researchers call for increased palliative care in China to address non-malignant disease management and family involvement. A systematic review highlights the need for better pain control, truth-telling, and emotional support.
Researchers found that angiotensin receptor blockers (ARBs), commonly used for high blood pressure and heart failure, may increase the likelihood of responding to anti-PD(L)1 therapy. Patients taking ARBs showed a statistically significant improvement in objective response rate and complete response rate compared to those not taking them.
Researchers at the University of South Australia have developed a novel microfluidic approach to purify CAR-T cells, reducing dead cells by over 70% and increasing cell viability by 20%. This method could significantly benefit patients by lowering manufacturing costs and side effects associated with CAR T cell therapy.
Researchers at UC have identified metabolic fingerprints that distinguish cancers from nonsmokers compared to smokers, providing important steps toward new and better therapeutic strategies for kidney cancers in both smoking and nonsmoking populations. The study reveals a separate metabolic subtype of kidney cancer with different weakn...
Researchers at UArizona Health Sciences have identified a biomarker, MiR130b, that appears in patients before stomach cancer develops. The biomarker can be detected through a simple blood test, potentially saving time and lowering costs compared to current diagnostic procedures.
Non-invasive ventilation use increased nine-fold between 2000 and 2017, but data on its effectiveness for cancer and dementia patients is lacking. The therapy may prolong suffering for patients near the end of life.
A novel combination of immunotherapy targeting CTLA-4 and PD-1 led to a rapid and complete response in a 19-year-old patient with stage 4 epithelioid sarcoma. The patient achieved complete remission within two weeks, resuming normal activities and physical examination.
Baseline ctDNA levels predicted responses to first-line immune checkpoint inhibition in patients with melanoma, but not second-line treatment. Low ctDNA levels associated with longer progression-free survival in both discovery and validation cohorts.
A Penn-developed machine learning tool helps sustain end-of-life care discussions with cancer patients, tripling the rate of those discussions. The study shows that clinicians engage more in conversations when prompted by an algorithm and a behavioral nudge.
The NCI-MATCH trial, the largest precision medicine cancer trial to date, has made significant contributions to the use of tumor gene testing in selecting treatment for patients. The study found that nearly 40% of patients have matching tumor gene defects for targeted treatments.
A new study led by Massachusetts General Hospital found that frequent phone counseling significantly improves quit rates among cancer patients who smoke. The intensive program resulted in a 34.5% abstinence rate, compared to 21.5% for those receiving less frequent counseling.
Research shows that intensive smoking cessation counseling for newly diagnosed cancer patients improves quality of life, reduces complications and increases survival. The study found that providing six months of inexpensive tobacco cessation support at diagnosis can result in significant cost savings and improved health outcomes.
A Phase I trial found neoadjuvant combination immunotherapy with tremelimumab and durvalumab showed early signs of activity in patients with high-risk disease, with a pathologic complete response rate of 37.5%.
A new urine-based liquid biopsy test, UroCAD, has been developed to detect bladder cancer with higher sensitivity and similar specificity compared to traditional urine cytology. The test analyzes DNA copy number variants in urine exfoliated cells and shows promise for reducing the frequency of cystoscopy examinations.
MUSC researchers have identified a new biomarker that may predict which patients are at risk of graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation. High levels of plasmacytoid dendritic cells expressing ICOS ligand are associated with increased severity of GVHD and lower survival rates.
A Yale professor has received a $500,000 grant to develop a versatile and highly scalable strategy for treating pancreatic cancer. The technology, called MAEGI, targets multiple differences in cancer cells and activates multiple immune system responses.
Researchers found that 91% of patients with limited stage DLBCL who received no radiation were alive five years after treatment. A PET scan after three cycles of R-CHOP can determine if patients need additional chemotherapy or radiation. This approach may improve patient outcomes and reduce toxicity.
The study reveals that while COVID-19 complicates cancer care, it also spurs innovative solutions to clinical challenges. Researchers found that patients with cancer are at heightened risk of severe illness due to weakened immune systems, but also highlighted the benefits of telemedicine and creative approaches to treatment.
Preliminary results from two large clinical trials investigating a new PD-1-based immune therapy for metastatic cervical cancer suggest improved response rates and potential new treatment options. The trials involved over 150 patients with recurrent or metastatic cervical cancer and tested the combination of balstilimab and zalifrelimab.
The SWOG Cancer Research Network will share innovative approaches to cancer care, including telemedicine and quality improvements, in response to the COVID-19 pandemic. The network's trials have led to significant advancements in cancer treatment and patient outcomes.
Pediatric brain cancer researcher Jezabel R. Blanco will receive a $300,000 grant to explore medulloblastoma, a subtype of brain tumor that tends to be particularly deadly in children under three. Her research aims to target the stem cell reservoir of these tumors and develop new treatments.
Researchers at UVA Cancer Center developed a set of metrics to evaluate care provided for brain metastases, aiming to enhance treatment decisions and coordination. The findings, published in JCO Oncology Practice, will help hospitals improve their interdisciplinary treatment programs.
Researchers discovered that cancer mutations follow specific patterns, with internal factors leading to enriched mutations in active domains and external factors resulting in mutations in inactive domains. This understanding may lead to new therapeutic targets and treatment options.
A major study of women with ductal carcinoma in situ (DCIS) found that surgery followed by radiotherapy offers better protection against invasive cancer. However, the benefit of radiotherapy decreases over time, suggesting a need for personalized treatment decisions.
Researchers found that patients receiving personalized cancer therapy had improved survival rates and longer progression-free periods compared to those with unmatched treatment plans. The use of next-generation sequencing allows for more precise targeting of cancer cells.
Researchers found high variability in DNA changes between individuals, suggesting a wide range of factors influence bladder cancer development. A new mutational signature linked to smoking was also identified, shedding light on why tobacco is the single greatest risk factor for bladder cancer.
A recent study published in CA: A Cancer Journal for Clinicians found that little effort has been made to increase older adult participation in cancer clinical trials, despite the disproportionate impact of cancer on this age group. The researchers called for a more inclusive approach, recommending that trials ask targeted questions an...
Catherine Marinac receives Sharp Tank Award to study health disparities in multiple myeloma and tailor interventions for diverse patient populations. The award supports research on early intervention and treatment for precursor multiple myeloma, a rare blood cancer disproportionately affecting people of color.
Researchers at the University of Colorado Cancer Center found that disparities in cancer outcomes for Black patients are largely caused by unequal access to healthcare. The study examined Medicare data for individuals with squamous cell cancer of the head and neck, controlling for factors such as stage of diagnosis and treatment receiv...
Researchers at MUSC Hollings Cancer Center identified multiple obstacles that prevent head and neck cancer patients from receiving timely radiation treatment, leading to worse survival outcomes. The study presents a novel framework for understanding these barriers and aims to improve patient care through an intervention strategy.
A new CDK 4/6 inhibitor, abemaciclib, has been shown to reduce the risk of breast cancer recurrence in high-risk patients with hormone receptor-positive (HR+) early-stage disease by 25%. The monarchE study found that adding abemaciclib to standard hormone therapy significantly improved patient outcomes.
A repeated testing protocol for COVID-19 among patients with cancer was examined in a quality improvement study. The study found that asymptomatic cancer patients can be safely screened for COVID-19 without increasing the risk of infection.
A clinical trial of selpercatinib has shown promising results for patients with non-small cell lung cancer, achieving high response rates and prolonged survival. The drug specifically targets cancers driven by mutations in the gene RET, with minimal side effects.
Genetic testing is cost-effective for newly diagnosed metastatic GIST patients, enabling clinicians to prescribe tumor-specific chemotherapy. This approach avoids ineffective treatment and reduces disease progression rates.
A new app called Close2U has been developed to monitor the physical and mental health of cancer patients using gamification. The app rewards users with advice or songs for answering daily questions about their mood and pain levels, promoting motivation and continuous monitoring.
A new bioinformatics tool called DrBioRight has been developed to enable biomedical researchers to conduct routine analyses of large datasets without specialized expertise in bioinformatics or programming languages. The tool uses a natural-language interface to allow users to ask questions and receive intuitive analysis results.
The National Comprehensive Cancer Network has published a new patient and caregiver resource focused on childhood cancer type, pediatric acute lymphoblastic leukemia. The guidelines provide easy-to-understand information on treatment options, including charts and images, to help patients and caregivers make informed decisions.
Research suggests that cancer patients with COVID-19 have a higher mortality rate due to their age and comorbidities, rather than the cancer. The study found that survival at 30 days was worse in cancer patients compared to non-cancer patients.
A national survey found that many cancer patients lack nutritional advice and face difficulties such as diarrhoea, appetite loss, and changes in taste and smell. Researchers emphasize the importance of individualized guidance for improved quality of life and overall survival.